An integrative overview on the mechanisms underlying the renal tubular cytotoxicity of gentamicin

Toxicological Sciences

Volumn 119, Issue 2, 2011, Pages 245-256

  Quiros, Yaremi ^a,b,c   Vicente Vicente, Laura ^a,b   Morales, Ana I ^a,b   López Novoa, José M ^a,b   López Hernández, Francisco J ^a,b,d  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b Instituto Reina Sofía de Investigación Nefrológica Fundación Iñigo Álvarez de Toledo   (Spain)

^c Bio inRen SL   (Spain)

^d HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Aminoglycoside antibiotics; Apoptosis; Cytotoxicity; Gentamicin; Necrosis

Indexed keywords

CALCIUM SENSING RECEPTOR; CATHEPSIN; CELL RECEPTOR; GENTAMICIN; MEGALIN;

APOPTOSIS; ARTICLE; BRUSH BORDER; CELL DEATH; CELL LEVEL; DRUG CYTOTOXICITY; DRUG EFFECT; ENDOPLASMIC RETICULUM STRESS; GOLGI COMPLEX; HUMAN; INFLAMMATION; KIDNEY BLOOD FLOW; KIDNEY EPITHELIUM; KIDNEY TUBULE CELL; KIDNEY TUBULE NECROSIS; LIPIDOSIS; MITOCHONDRION; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN DEGRADATION;

NEGIBACTERIA;

EID: 78751687938     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfq267     Document Type: Article

References (131)

1. Abdel-Gayoum, A. A., Ali, B. H., Ghawarsha, K., and Bashir, A. A. (1993). Plasma lipid profile in rats with gentamicin-induced nephrotoxicity. Hum. Exp. Toxicol. 12, 371-375.
2. Ali, B. H. (2003). Agents ameliorating or augmenting experimental gentamicin nephrotoxicity: some recent research. Food. Chem. Toxicol. 41, 1447-1452.
3. Ali, B. H., Abdel Gayoum, A. A., and Bashir, A. A. (1992). Gentamicin nephrotoxicity in rat: some biochemical correlates. Pharmacol. Toxicol. 70, 419-423.
4. Basnakian, A. G., Kaushal, G. P., and Shah, S. V. (2002). Apoptotic pathways of oxidative damage to renal tubular epithelial cells. Antioxid. Redox Signal. 4, 915-924.
5. Bennett, W. M., Mela-Riker, L. M., Houghton, D. C., Gilbert, D. N., and Buss, W. C. (1988). Microsomal protein synthesis inhibition: an early manifestation of gentamicin nephrotoxicity. Am. J. Physiol. 255, F265-F269.
6. Bledsoe, G., Crickman, S., Mao, J., Xia, C. F., Murakami, H., Chao, L., and Chao, J. (2006). Kallikrein/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosis. Nephrol. Dial. Transplant. 21, 624-633.
7. Buchanan, J. H., Stevens, A., and Sidhu, J. (1987). Aminoglycoside antibiotic treatment of human fibroblasts: intracellular accumulation, molecular changes and the loss of ribosomal accuracy. Eur. J. Cell Biol. 43, 141-147.
8. Chiarugi, A. (2005). "Simple but not simpler": toward a unified picture of energy requirements in cell death. FASEB J. 19, 1783-1788.
9. Chwieralski, C. E., Welte, T., and Bühling, F. (2006). Cathepsin-regulated apoptosis. Apoptosis 11, 143-149.
10. Cui, S., Verroust, P. J., Moestrup, S. K., and Christensen, E. I. (1996). Megalin/gp330 mediates uptake of albumin in renal proximal tubule. Am. J. Physiol. 271, F900-F907.
11. Cuzzocrea, S., Mazzon, E., Dugo, L., Serraino, I., Di Paola, R., Britti, D., De Sarro, A., Pierpaoli, S., Caputi, A., Masini, E., et al. (2002). A role for superoxide in gentamicin-mediated nephropathy in rats. Eur. J. Pharmacol. 450, 67-76.
12. Cuzzocrea, S., Thiemermann, C., and Salvemini, D. (2004). Potential therapeutic effect of antioxidant therapy in shock and inflammation. Curr. Med. Chem. 11, 1147-1462.
13. De Broe, M. E., Paulus, G. J., Verpooten, G. A., Roels, F., Buyssens, N., Wedeen, R., Van Hoof, F., and Tulkens, P. M. (1984). Early effects of gentamicin, tobramycin, and amikacin on the human kidney. Kidney Int. 25, 643-652.
14. DiBona, D. R., and Powell, W. J., Jr. (1980). Quantitative correlation between cell swelling and necrosis in myocardial ischemia in dogs. Circ. Res. 47, 653-665.
15. Dos Santos, O. F., Boim, M. A., Barros, E. J., and Schor, N. (1991). Role of platelet activating factor in gentamicin and cisplatin nephrotoxicity. Kidney Int. 40, 742-747.
16. Edinger, A. L., and Thompson, C. B. (2004). Death by design: apoptosis, necrosis and autophagy. Curr. Opin. Cell Biol. 16, 663-669.
17. Edwards, C. Q., Smith, C. R., Baughman, K. L., Rogers, J. F., and Lietman, P. S. (1976). Concentrations of gentamicin and amikacin in human kidneys. Antimicrob. Agents Chemother. 9, 925-927.
18. Edwards, J. R., Diamantakos, E. A., Peuler, J. D., Lamar, P. C., and Prozialeck, W. C. (2007). A novel method for the evaluation of proximal tubule epithelial cellular necrosis in the intact rat kidney using ethidium homodimer. BMC Physiol. 7, 1.
19. El Mouedden, M., Laurent, G., Mingeot-Leclercq, M. P., and Tulkens, P. M. (2000). Gentamicin-induced apoptosis in renal cell lines and embryonic rat fibroblasts. Toxicol. Sci. 56, 229-239.
20. Forge, A., Zajic, G., Davies, S., Weiner, N., and Schacht, J. (1989). Gentamicin alters membrane structure as shown by freeze-fracture of liposomes. Hear. Res. 37, 129-139.
21. Förstermann, U. (2010). Nitric oxide and oxidative stress in vascular disease. Pflugers Arch. 459, 923-939.
22. Fribley, A., Zhang, K., and Kaufman, R. J. (2009). Regulation of apoptosis by the unfolded protein response. Methods Mol. Biol. 559, 191-204.
23. Frommer, J. P., Senekjian, H. O., Babino, H., and Weinman, E. J. (1983). Intratubular microinjection study of gentamicin transport in the rat. Miner. Electrolyte Metab. 9, 108-112.
24. Fukuda, Y., Malmborg, A. S., and Aperia, A. (1991). Gentamicin inhibition of Na+, K(+)-ATPase in rat kidney cells. Acta Physiol. Scand. 141, 27-34.
25. Gibbons, C. E., Maldonado-Pérez, D., Shah, A. N., Riccardi, D., and Ward, D. T. (2008). Calcium-sensing receptor antagonism or lithium treatment ameliorates aminoglycoside-induced cell death in renal epithelial cells. Biochim. Biophys. Acta 1782, 188-195.
26. Giuliano, R. A., Paulus, G. J., Verpooten, G. A., Pattyn, V. M., Pollet, D. E., Nouwen, E. J., Laurent, G., Carlier, M. B., Maldague, P., Tulkens, P. M., et al. (1984). Recovery of cortical phospholipidosis and necrosis after acute gentamicin loading in rats. Kidney Int. 26, 838-847.
27. Giurgea-Marion, L., Toubeau, G., Laurent, G., Heuson-Stiennon, J. A., and Tulkens, P. M. (1986). Impairment of lysosome-pinocytic vesicle fusion in rat kidney proximal tubules after treatment with gentamicin at low doses. Toxicol. Appl. Pharmacol. 86, 271-285.
28. Golstein, P., and Kroemer, G. (2007). Cell death by necrosis: towards a molecular definition. Trends Biochem. Sci. 32, 37-43.
29. Hishida, A., Nakajima, T., Yamada, M., Kato, A., and Honda, N. (1994). Roles of hemodynamic and tubular factors in gentamicin-mediated nephropathy. Ren. Fail. 16, 109-116.
30. Horibe, T., Matsui, H., Tanaka, M., Nagai, H., Yamaguchi, Y., Kato, K., and Kikuchi, M. (2004). Gentamicin binds to the lectin site of calreticulin and inhibits its chaperone activity. Biochem. Biophys. Res. Commun. 323, 281-287.
31. Houghton, D. C., Campbell-Boswell, M. V., Bennett, W. M., Porter, G. A., and Brooks, R. E. (1978). Myeloid bodies in the renal tubules of humans: relationship to gentamicin therapy. Clin. Nephrol. 10, 140-145.
32. Hsu, Y. H., Chen, C. H., Hou, C. C., Sue, Y. M., Cheng, C. Y., Cheng, T. H., Lin, H., Tsai, W. L., Chan, P., and Chen, T. H. (2008). Prostacyclin protects renal tubular cells from gentamicin-induced apoptosis via a PPARalphadependent pathway. Kidney Int. 73, 578-587.
33. Jeong, J. I., Lee, Y. W., and Kim, Y. K. (2003). Chemical hypoxia-induced cell death in human glioma cells: role of reactive oxygen species, ATP depletion, mitochondrial damage and Ca2+. Neurochem. Res. 28, 1201-1211.
34. Jones, A. T., and Wessling-Resnick, M. (1998). Inhibition of in vitro endosomal vesicle fusion activity by aminoglycoside antibiotics. J. Biol. Chem. 273, 25301-25309.
35. Juan, S. H., Chen, C. H., Hsu, Y. H., Hou, C. C., Chen, T. H., Lin, H., Chu, Y. L., and Sue, Y. M. (2007). Tetramethylpyrazine protects rat renal tubular cell apoptosis induced by gentamicin. Nephrol. Dial. Transplant. 22, 732-739.
36. Justo, P., Sanz, A. B., Sanchez-Niño, M. D., Winkles, J. A., Lorz, C., Egido, J., and Ortiz, A. (2006). Cytokine cooperation in renal tubular cell injury: the role of TWEAK. Kidney Int. 70, 1750-1758.
37. Kacew, S. (1987). Cationic amphiphilic drug-induced renal cortical lysosomal phospholipidosis: an in vivo comparative study with gentamicin and chlorphentermine. Toxicol. Appl. Pharmacol. 91, 469-476.
38. Kadkhodaee, M., Khastar, H., Arab, H. A., Ghaznavi, R., Zahmatkesh, M., and Mahdavi-Mazdeh, M. (2007). Antioxidant vitamins preserve superoxide dismutase activities in gentamicin-induced nephrotoxicity. Transplant. Proc. 39, 864-865.
39. Kadkhodaee, M., Khastar, H., Faghihi, M., Ghaznavi, R., and Zahmatkesh, M. (2005). Effects of co-supplementation of vitamins E and C on gentamicininduced nephrotoxicity in rat. Exp. Physiol. 90, 571-576.
40. Kalayarasan, S., Prabhu, P. N., Sriram, N., Manikandan, R., Arumugam, M., and Sudhandiran, G. (2009). Diallyl sulfide enhances antioxidants and inhibits inflammation through the activation of Nrf2 against gentamicininduced nephrotoxicity in Wistar rats. Eur. J. Pharmacol. 606, 162-171.
41. Kaloyanides, G. J. (1992). Drug-phospholipid interactions: role in aminoglycoside nephrotoxicity. Ren. Fail. 14, 351-357.
42. Karasawa, T., Wang, Q., Fu, Y., Cohen, D. M., and Steyger, P. S. (2008). TRPV4 enhances the cellular uptake of aminoglycoside antibiotics. J. Cell Sci. 121, 2871-2879.
43. Karatasx, Y., Secxilmisx, M. A., Karayaylali, I., Doran, F., Büyükafsxar, K., Singirik, E., Sagliker, Y., and Dikmen, A. (2004). Effect of tempol (4-hydroxy tempo) on gentamicin-induced nephrotoxicity in rats. Fundam. Clin. Pharmacol. 18, 79-83.
44. Karkar, A. (2008). Modulation of renal inflammation: therapeutic strategies. Saudi J. Kidney Dis. Transpl. 19, 1-19.
45. Kerbiriou, M., Teng, L., Benz, N., Trouvé, P., and Férec, C. (2009). The calpain, caspase 12, caspase 3 cascade leading to apoptosis is altered in F508del-CFTR expressing cells. PloS One 4, e8436.
46. Kiang, J. G., and Tsen, K. T. (2006). Biology of hypoxia. Chin. J. Physiol. 49, 223-233.
47. Kim, I., Xu, W., and Reed, J. C. (2008). Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat. Rev. Drug Discov. 7, 1013-1030.
48. Kishore, B. K., Lambricht, P., Ibrahim, S., Laurent, G., Tulkens, P. M., and Maldague, P. (1990). Inhibition of aminoglycoside-induced nephrotoxicity in rats by polyanionic peptides. Contrib. Nephrol. 83, 191-201.
49. Kourilsky, O., Solez, K., Morel-Maroger, L., Whelton, A., Duhoux, P., and Sraer, J. D. (1982). The pathology of acute renal failure due to interstitial nephritis in man with comments on the role of interstitial inflammation and sex in gentamicin nephrotoxicity. Medicine (Baltimore) 61, 258-268.
50. Koyner, J. L., Sher Ali, R., and Murray, P. T. (2008). Antioxidants. Do they have a place in the prevention or therapy of acute kidney injury? Nephron. Exp. Nephrol. 109, e109-e117.
51. Lai, E., Teodoro, T., and Volchuk, A. (2007). Endoplasmic reticulum stress: signalling the unfolded protein response. Physiology (Bethesda) 22, 193-201.
52. Laurent, G., Carlier, M. B., Rollman, B., Van Hoof, F., and Tulkens, P. (1982). Mechanism aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin. Biochem. Pharmacol. 31, 3861-3870.
53. Lee, B. H., Lee, S. H., Choi, H. J., Kang, H. G., Oh, S. W., Lee, D. S., Ha, I. S., Choi, Y., and Cheong, H. I. (2009). Decreased renal uptake of (99m)Tc-DMSA in patients with tubular proteinuria. Pediatr. Nephrol. 24, 2211-2216.
54. Levi, M., and Cronin, R. E. (1990). Early selective effects of gentamicin on renal brush-border membrane Na-Pi cotransport and Na-H exchange. Am. J. Physiol. 258, F1379-F1387.
55. Li, J., Li, Q. X., Xie, X. F., Ao, Y., Tie, C. R., and Song, R. J. (2009a). Differential roles of dihydropyridine calcium antagonist nifedipine, nitrendipine and amlodipine on gentamicin-induced renal tubular toxicity in rats. Eur. J. Pharmacol. 620, 97-104.
56. Li, S., Nagothu, K. K., Desai, V., Lee, T., Branham, W., Moland, C., Megyesi, J. K., Crew, M. D., and Portilla, D. (2009b). Transgenic expression of proximal tubule peroxisome proliferator-activated receptor-alpha in mice confers protection during acute kidney injury. Kidney Int. 76, 1049-1062.
57. Li, S., Wu, P., Yarlagadda, P., Vadjunec, N. M., Proia, A. D., Harris, R. A., and Portilla, D. (2004). PPAR alpha ligand protects during cisplatin-induced acute renal failure by preventing inhibition of renal FAO and PDC activity. Am. J. Physiol. Renal Physiol. 286, F572-F580.
58. Lieberthal, W., and Levine, J. S. (1996). Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am. J. Physiol. 271, F477-F488.
59. Lin, H., Hou, C. C., Cheng, C. F., Chiu, T. H., Hsu, Y. H., Sue, Y. M., Chen, T. H., Hou, H. H., Chao, Y. C., Cheng, T. H., et al. (2007). Peroxisomal proliferator-activated receptor-alpha protects renal tubular cells from doxorubicin-induced apoptosis. Mol. Pharmacol. 72, 1238-1245.
60. Lipsky, J. J., Cheng, L., Sacktor, B., and Lietman, P. S. (1980). Gentamicin uptake by renal tubule brush border membrane vesicles. J. Pharmacol. Exp. Ther. 215, 390-393.
61. Lopez-Hernandez, F. J., and Lopez-Novoa, J. M. (2009). Potential utility of PPARalpha activation in the prevention of ischemic and drug-induced acute renal damage. Kidney Int. 76, 1022-1024.
62. López-Novoa, J. M. (1999). Potential role of platelet activating factor in acute renal failure. Kidney Int. 55, 1672-1682.
63. Lu, H., Zhen, J., Wu, T., Peng, A., Ye, T., Wang, T., Yu, X., Vaziri, N. D., Mohan, C., and Zhou, X. J. (2010). Superoxide dismutase mimetic drug tempol aggravates anti-GBM antibody induced glomerulonephritis in mice. Am. J. Physiol. Renal Physiol. 299, F445-F452.
64. Luft, F. C., Yum, M. N., Walker, P. D., and Kleit, S. A. (1977). Gentamicin gradient patterns and morphological changes in human kidneys. Nephron 18, 167-174.
65. Maldonado, P. D., Barrera, D., Rivero, I., Mata, R., Medina-Campos, O. N., Hernández-Pando, R., and Pedraza-Chaverrí, J. (2003). Antioxidant S-allylcysteine prevents gentamicin-induced oxidative stress and renal damage. Free Radic. Biol. Med. 35, 317-324.
66. Martínez-Salgado, C., Eleno, N., Tavares, P., Rodríguez-Barbero, A., García-Criado, J., Bolaños, J. P., and López-Novoa, J. M. (2002). Involvement of reactive oxygen species on gentamicin-induced mesangial cell activation. Kidney Int. 62, 1682-1692.
67. Martínez-Salgado, C., López-Hernández, F. J., and López-Novoa, J. M. (2007). Glomerular nephrotoxicity of aminoglycosides. Toxicol. Appl. Pharmacol. 223, 86-98.
68. Mather, M., and Rottenberg, H. (2001). Polycations induce the release of soluble intermembrane mitochondrial proteins. Biochim. Biophys. Acta 1503, 357-368.
69. Meyer, M., Schreck, R., and Baeuerle, P. A. (1993). H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12, 2005-2015.
70. Mingeot-Leclercq, M. P., Brasseur, R., and Schanck, A. (1995). Molecular parameters involved in aminoglycoside nephrotoxicity. J. Toxicol. Environ. Health 44, 263-300.
71. Mingeot-Leclercq, M. P., and Tulkens, P. M. (1999). Aminoglycosides: nephrotoxicity. Antimicrob. Agents Chemother. 43, 1003-1012.
72. Moestrup, S. K., Cui, S., Vorum, H., Bregengard, C., Bjorn, S. E., Norris, K., Gliemann, J., and Christensen, E. I. (1995). Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. J. Clin. Invest. 96, 1404-1413.
73. Monteil, C., Leclere, C., Fillastre, J. P., and Morin, J. P. (1993). Characterization of gentamicin-induced dysfunctions in vitro: the use of optimized primary cultures of rabbit proximal tubule cells. Ren. Fail. 15, 475-483.
74. Morales, A. I., Buitrago, J. M., Santiago, J. M., Fernández-Tagarro, M., López-Novoa, J. M., and Pérez-Barriocanal, F. (2002). Protective effect of trans-resveratrol on gentamicin-induced nephrotoxicity. Antioxid. Redox Signal. 4, 893-898.
75. Morales, A. I., Detaille, D., Prieto, M., Puente, A., Briones, E., Arévalo, M., Leverve, X., López-Novoa, J. M., and El-Mir, M. Y. (2010). Metformin prevents experimental gentamicin-induced nephropathy by a mitochondriadependent pathway. Kidney Int. 77, 861-869.
76. Moran, K., Mulhall, J., Kelly, D., Sheehan, S., Dowsett, J., Dervan, P., and Fitzpatrick, J. M. (1992). Morphological changes and alterations in regional intrarenal blood flow induced by graded renal ischemia. J. Urol. 148, 463-466.
77. Morgan, M. J., Kim, Y. S., and Liu, Z. (2007). Lipid rafts and oxidative stressinduced cell death. Antioxid. Redox Signal. 9, 1471-1483.
78. Myrdal, S. E., Johnson, K. C., and Steyger, P. S. (2005). Cytoplasmic and intranuclear binding of gentamicin does not require endocytosis. Hear. Res. 204, 156-169.
79. Nagai, J., Katsube, T., Murakami, T., and Takano, M. (2002). Effect of gentamicin on pharmacokinetics of lysozyme in rats: interaction between megalin substrates in the kidney. J. Pharm. Pharmacol. 54, 1491-1496.
80. Nagai, J., Saito, M., Adachi, Y., Yumoto, R., and Takano, M. (2006). Inhibition of gentamicin binding to rat renal brush-border membrane by megalin ligands and basic peptides. J. Control. Release 112, 43-50.
81. Nakajima, T., Hishida, A., and Kato, A. (1994). Mechanisms for protective effects of free radical scavengers on gentamicin-mediated nephropathy in rats. Am. J. Physiol. 266, F425-F431.
82. Ngaha, E. O., and Ogunleye, I. O. (1983). Studies on gentamicin-induced labilization of rat kidney lysosomes in vitro. Possible protection by selenium. Biochem. Pharmacol. 32, 2659-2664.
83. Nonclercq, D., Wrona, S., Toubeau, G., Zanen, J., Heuson-Stiennon, J. A., Schaudies, R. P., and Laurent, G. (1992). Tubular injury and regeneration in the rat kidney following acute exposure to gentamicin: a time-course study. Ren. Fail. 14, 507-521.
84. Ott, M., Gogvadze, V., Orrenius, S., and Zhivotovsky, B. (2007). Mitochondria, oxidative stress and cell death. Apoptosis 12, 913-922.
85. Papanikolaou, N., Peros, G., Morphake, P., Gkikas, G., Maraghianne, D., Tsipas, G., Kostopoulos, K., Arambatze, C., Gkika, E. L., and Bariety, J. (1992). Does gentamicin induce acute renal failure by increasing renal TXA2 synthesis in rats? Prostaglandins Leukot. Essent. Fatty Acids 45, 131-136.
86. Pedraza-Chaverrí, J., Barrera, D., Maldonado, P. D., Chirino, Y. I., Macías-Ruvalcaba, N. A., Medina-Campos, O. N., Castro, L., Salcedo, M. I., and Hernández-Pando, R. (2004). S-allylmercaptocysteine scavenges hydroxyl radical and singlet oxygen in vitro and attenuates gentamicin-induced oxidative and nitrosative stress and renal damage in vivo. BMC Clin. Pharmacol. 4, 5.
87. Pessoa, E. A., Convento, M. B., Silva, R. G., Oliveira, A. S., Borges, F. T., and Schor, N. (2009). Gentamicin-induced preconditioning of proximal tubular LLC-PK1 cells stimulates nitric oxide production but not the synthesis of heat shock protein. Braz. J. Med. Biol. Res. 42, 614-620.
88. Peyrou, M., and Cribb, A. E. (2007). Effect of endoplasmic reticulum stress preconditioning on cytotoxicity of clinically relevant nephrotoxins in renal cell lines. Toxicol. In Vitro 21, 878-886.
89. Peyrou, M., Hanna, P. E., and Cribb, A. E. (2007). Cisplatin, gentamicin, and p-aminophenol induce markers of endoplasmic reticulum stress in the rat kidneys. Toxicol. Sci. 99, 346-353.
90. Ramsammy, L. S., Josepovitz, C., and Kaloyanides, G. J. (1988). Gentamicin inhibits agonist stimulation of the phosphatidylinositol cascade in primary cultures of rabbit proximal tubular cells and in rat renal cortex. J. Pharmacol. Exp. Ther. 247, 989-996.
91. Ramsammy, L. S., Josepovitz, C., Lane, B., and Kaloyanides, G. J. (1989a). Effect of gentamicin on phospholipid metabolism in cultured rabbit proximal tubular cells. Am. J. Physiol. 256, C204-C213.
92. Ramsammy, L. S., Josepovitz, C., Lane, B. P., and Kaloyanides, G. J. (1989b). Polyaspartic acid protects against gentamicin nephrotoxicity in the rat. J. Pharmacol. Exp. Ther. 250, 149-153.
93. Ramsammy, L., Josepovitz, C., Lane, B., and Kaloyanides, G. J. (1990). Polyaspartic acid inhibits gentamicin-induced perturbations of phospholipid metabolism. Am. J. Physiol. 258, C1141-C1149.
94. Recht, M. I., Douthwaite, S., and Puglisi, J. D. (1999). Basis for prokaryotic specificity of action of aminoglycoside antibiotics. EMBO J. 18, 3133-3138.
95. Regec, A. L., Trump, B. F., and Trifillis, A. L. (1989). Effect of gentamicin on the lysosomal system of cultured human proximal tubular cells. Endocytotic activity, lysosomal pH and membrane fragility. Biochem. Pharmacol. 38, 2527-2534.
96. Rodriguez-Barbero, A., Bosque, E., Rivas-Cabañero, L., Arévalo, M., and López-Novoa, J. M. (1992). Effect of platelet activating factor antagonist treatment on gentamicin nephrotoxicity. Mediators Inflamm. 1, 23-26.
97. Ryter, S. W., Kim, H. P., Hoetzel, A., Park, J. W., Nakahira, K., Wang, X., and Choi, A. M. (2007). Mechanisms of cell death in oxidative stress. Antioxid. Redox Signal. 9, 49-89.
98. Saito, Y., Nishio, K., Ogawa, Y., Kimata, J., Kinumi, T., Yoshida, Y., Noguchi, N., and Niki, E. (2006). Turning point in apoptosis/necrosis induced by hydrogen peroxide. Free Radic. Res. 40, 619-630.
99. Sánchez-López, E., Rayego, S., Rodrigues-Díez, R., Rodriguez, J. S., Rodrigues-Díez, R., Rodríguez-Vita, J., Carvajal, G., Aroeira, L. S., Selgas, R., Mezzano, S. A., et al. (2009). CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-kappaB. J. Am. Soc. Nephrol. 20, 1513-1526.
100. Sandhya, P., and Varalakshmi, P. (1997). Effect of lipoic acid administration on gentamicin-induced lipid peroxidation in rats. J. Appl. Toxicol. 17, 405-408.
101. Sandoval, R. M., and Molitoris, B. A. (2004). Gentamicin traffics retrograde through the secretory pathway and is released in the cytosol via the endoplasmic reticulum. Am. J. Physiol. Renal Physiol. 286, F617-F624.
102. Santos, C. X., Tanaka, L. Y., Wosniak, J., and Laurindo, F. R. (2009). Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase. Antioxid. Redox Signal. 11, 2409-2427.
103. Sato, T., Oku, H., Tsuruma, K., Katsumura, K., Shimazawa, M., Hara, H., Sugiyama, T., and Ikeda, T. (2010). Effect of hypoxia on susceptibility of RGC-5 cells to nitric oxide. Invest. Ophthalmol. Vis. Sci. 51, 2575-12486.
104. Schmitz, C., Hilpert, J., Jacobsen, C., Boensch, C., Christensen, E. I., Luft, F. C., and Willnow, T. E. (2002). Megalin deficiency offers protection from renal aminoglycoside accumulation. J. Biol. Chem. 277, 618-622.
105. Schnellmann, R. G., and Williams, S. W. (1998). Proteases in renal cell death: calpains mediate cell death produced by diverse toxicants. Ren. Fail. 20, 679-686.
106. Schreck, R., Rieber, P., and Baeuerle, P. A. (1991). Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10, 2247-2258.
107. Seçilmiş, M. A., Karataş, Y., Yorulmaz, O., Buyukafşar, K., Singirik, E., Doran, F., Inal, T. C., and Dikmen, A. (2005). Protective effect of L-arginine intake on the impaired renal vascular responses in the gentamicin-treated rats. Nephron Physiol. 100, 13-20.
108. Seppet, E., Gruno, M., Peetsalu, A., Gizatullina, Z., Nguyen, H. P., Vielhaber, S., Wussling, M. H., Trumbeckaite, S., Arandarcikaite, O., Jerzembeck, D., et al. (2009). Mitochondria and energetic depression in cell pathophysiology. Int. J. Mol. Sci. 10, 2252-2303.
109. Servais, H., Jossin, Y., Van Bambeke, F., Tulkens, P. M., and Mingeot-Leclercq, M. P. (2006). Gentamicin causes apoptosis at low concentrations in renal LLC-PK1 cells subjected to electroporation. Antimicrob. Agents Chemother. 50, 1213-1221.
110. Servais, H., Ortiz, A., Devuyst, O., Denamur, S., Tulkens, P. M., and Mingeot-Leclercq, M. P. (2008). Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms and potential approaches to modulation. Apoptosis 13, 11-32.
111. Shimizu, A., Takumida, M., Anniko, M., and Suzuki, M. (2003). Calpain and caspase inhibitors protect vestibular sensory cells from gentamicin ototoxicity. Acta Otolaryngol. 123, 459-465.
112. Silverblatt, F. (1982). Pathogenesis of nephrotoxicity of cephalosporins and aminoglycosides: a review of current concepts. Rev. Infect. Dis. 4(Suppl), S360-S365.
113. Silverblatt, F. J., and Kuehn, C. (1979). Autoradiography of gentamicin uptake by the rat proximal tubule cell. Kidney Int. 15, 335-345.
114. Simmons, C. F., Jr., Bogusky, R. T., and Humes, H. D. (1980). Inhibitory effects of gentamicin on renal mitochondrial oxidative phosphorylation. J. Pharmacol. Exp. Ther. 214, 709-715.
115. Skopicki, H. A., Zikos, D., Sukowski, E. J., Fisher, K. A., and Peterson, D. R. (1996). Gentamicin inhibits carrier-mediated dipeptide transport in kidney. Am. J. Physiol. 270, F531-F538.
116. Stratta, P., Segoloni, G. P., Canavese, C., Muzio, G., Dogliani, M., Serra, A., Allemandi, P., Salomone, M., Caramellino, C., and Canuto, R. (1994). Oxygen free radicals are not the main factor in experimental gentamicin nephrotoxicity. Ren. Fail. 16, 445-455.
117. Sue, Y. M., Cheng, C. F., Chang, C. C., Chou, Y., Chen, C. H., and Juan, S. H. (2009). Antioxidation and anti-inflammation by haem oxygenase-1 contribute to protection by tetramethylpyrazine against gentamicin-induced apoptosis in murine renal tubular cells. Nephrol. Dial. Transplant. 24, 769-777.
118. Sundin, D. P., Sandoval, R., and Molitoris, B. A. (2001). Gentamicin inhibits renal protein and phospholipid metabolism in rats: implications involving intracellular trafficking. J. Am. Soc. Nephrol. 12, 114-123.
119. Swan, S. K., Kohlhepp, S. J., Kohnen, P. W., Gilbert, D. N., and Bennett, W. M. (1991). Long-term protection of polyaspartic acid in experimental gentamicin nephrotoxicity. Antimicrob. Agents Chemother. 35, 2591-2595.
120. Todd, J. H., Sens, D. A., Hazen-Martin, D. J., Bylander, J. E., Smyth, B. J., and Sens, M. A. (1992). Aminoglycoside antibiotics alter the electrogenic transport properties of cultured human proximal tubule cells. Toxicol. Pathol. 20, 608-616.
121. Trivedi, R., Mithal, A., and Chattopadhyay, N. (2008). Recent updates on the calcium-sensing receptor as a drug target. Curr. Med. Chem. 15, 178-186.
122. Tugcu, V., Ozbek, E., Tasci, A. I., Kemahli, E., Somay, A., Bas, M., Karaca, C., Altug, T., Cekmen, M. B., and Ozdogan, H. K. (2006). Selective nuclear factor kappa-B inhibitors, pyrolidium dithiocarbamate and sulfasalazine, prevent the nephrotoxicity induced by gentamicin. BJU Int. 98, 680-686.
123. Tulkens, P. M. (1989). Nephrotoxicity of aminoglycoside antibiotics. Toxicol. Lett. 46, 107-123.
124. Van Rooijen, L. A., and Agranoff, B. W. (1985). Inhibition of polyphosphoinositide phosphodiesterase by aminoglycoside antibiotics. Neurochem. Res. 10, 1019-1024.
125. Ward, D. T., Maldonado-Pérez, D., Hollins, L., and Riccardi, D. (2005). Aminoglycosides induce acute cell signalling and chronic cell death in renal cells that express the calcium-sensing receptor. J. Am. Soc. Nephrol. 16, 1236-1244.
126. Wu, Y., Connors, D., Barber, L., Jayachandra, S., Hanumegowda, U. M., and Adams, S. P. (2009). Multiplexed assay panel of cytotoxicity in HK-2 cells for detection of renal proximal tubule injury potential of compounds. Toxicol. In Vitro 23, 1170-1178.
127. Xie, Q. W., Kashiwabara, Y., and Nathan, C. (1994). Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269, 4705-4708.
128. Yang, C. L., Du, X. H., and Han, Y. X. (1995). Renal cortical mitochondria are the source of oxygen free radicals enhanced by gentamicin. Ren. Fail. 17, 21-26.
129. Yin, X. M. (2006). Bid, a BH3-only multi-functional molecule, is at the cross road of life and death. Gene 369, 7-19.
130. Yokouchi, M., Hiramatsu, N., Hayakawa, K., Okamura, M., Du, S., Kasai, A., Takano, Y., Shitamura, A., Shimada, T., Yao, J., et al. (2008). Involvement of selective reactive oxygen species upstream of proapoptotic branches of unfolded protein response. J. Biol. Chem. 283, 4252-4260.
131. Zhang, F., Hamanaka, R. B., Bobrovnikova-Marjon, E., Gordan, J. D., Dai, M. S., Lu, H., Simon, M. C., and Diehl, J. A. (2006). Ribosomal stress couples the unfolded protein response to p53-dependent cell cycle arrest. J. Biol. Chem. 281, 30036-30045.